Medical Reform Still Has Friends In GA Caucus

Gemini Sparkle

Key Takeaways:

  • New leadership in Congressional GA caucuses (Senate: Boozman & Manchin; House: Graves & Veasey) will advance third-class medical reform.
  • The Department of Transportation (DOT) will complete its review of FAA's proposed medical reforms by Monday, moving the process towards a public comment period.
  • AOPA criticized the DOT for delays in the review process, advocating for both legislative and regulatory solutions.
  • Proposed reforms aim to eliminate the third-class medical requirement for certain pilots and aircraft.
See a mistake? Contact us.

Advocates of third-class medical reform hope their campaign will forge ahead with help from new leadership announced this week in the Congressional GA caucuses. Sens. John Boozman, R-Ark., and Joe Manchin, D-W.V., will co-chair the Senate caucus. In the House, Reps. Sam Graves, R-Mo., and Marc Veasey, D-Texas, will serve as co-chairs. Boozman and Graves (also a member of the House Aviation Subcommittee) had previously spearheaded medical reform legislation that would eliminate the third-class medical requirement for some pilots and aircraft beyond the light-sport rules.

Also this week, the Department of Transportation said it will complete its overdue review of the FAA’s proposed medical reforms on Monday. When the DOT does finish its review, it checks off another step in the rulemaking process that will eventually include a public comment period. The announcements come about a week after AOPA President Mark Baker sent a letter to the DOT, criticizing the agency for taking several months to complete what was supposed to be a 90-day review of the proposal.”The general aviation community has waited too long for medical reform,”Baker said in a statement Thursday.”We will keep pushing for action on every possible front, including seeking a legislative solution with help from our friends in Congress.”

Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Please support AVweb.

It looks like you’re using an ad blocker. Ads keep AVweb free and fund our reporting.
Please whitelist AVweb or continue with ads enabled.